SCHEMBL196364

SCHEMBL196364

Nc1ccc2c(c1)C1(c3ccccc3-2)c2ccccc2-c2ccc(N)cc21

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.61
LMNA P02545 3/20 0.61
KDM4E B2RXH2 3/20 0.61
MAPT P10636 3/20 0.61
MEN1 O00255 3/20 0.61
KMT2A Q03164 3/20 0.61
OPRK1 P41145 1/20 0.61
PDK2 Q15119 3/20 0.58
ALDH1A1 P00352 5/20 0.48
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
HPGD P15428 2/20 0.48
CYP3A4 P08684 5/20 0.47
TDP1 Q9NUW8 2/20 0.47
TSHR P16473 2/20 0.47
TP53 P04637 1/20 0.47
MAPK1 P28482 1/20 0.47
PTPRC P08575 2/20 0.45
POLB P06746 2/20 0.45
APAF1 O14727 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29571766 1.00 SMN1; SMN2 (0.61) SMN1; SMN2LMNAKDM4EMAPTMEN1
SCHEMBL30041848 1.00 SMN1; SMN2 (0.61) SMN1; SMN2LMNAKDM4EMAPTMEN1
SCHEMBL25632111 1.00 SMN1; SMN2 (0.61) SMN1; SMN2LMNAKDM4EMAPTMEN1
SCHEMBL808149 1.00 SMN1; SMN2 (0.61) SMN1; SMN2LMNAKDM4EMAPTMEN1
SCHEMBL15695611 1.00 SMN1; SMN2 (0.61) SMN1; SMN2LMNAKDM4EMAPTMEN1
SCHEMBL29362874 1.00 SMN1; SMN2 (0.61) SMN1; SMN2LMNAKDM4EMAPTMEN1
SCHEMBL14174132 0.98 SMN1; SMN2 (0.59) SMN1; SMN2LMNAKDM4EMAPTMEN1
SCHEMBL16384351 0.96 SMN1; SMN2 (0.57) SMN1; SMN2LMNAKDM4EMAPTMEN1
SCHEMBL20821453 0.96 SMN1; SMN2 (0.57) SMN1; SMN2LMNAKDM4EMAPTMEN1
SCHEMBL20821450 0.96 SMN1; SMN2 (0.57) SMN1; SMN2LMNAKDM4EMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7183010-B2 Organic light-emitting diode devices with improved operational stability EASTMAN KODAK CORPORATION (US) 2007-02-27 US claimed
US-7175922-B2 Aggregate organic light emitting diode devices with improved operational stability EASTMAN KODAK COMPANY (US) 2007-02-13 US claimed
US-20060141287-A1 OLEDs with improved operational lifetime EASTMAN KODAK COMPANY 2006-06-29 US claimed
US-20060040131-A1 OLEDs with improved operational lifetime EASTMAN KODAK COMPANY 2006-02-23 US claimed
US-20050106415-A1 Aggregate organic light emitting diode devices with improved operational stability EASTMAN KODAK COMPANY 2005-05-19 US claimed
US-20040076853-A1 Organic light-emitting diode devices with improved operational stability EASTMAN KODAK COMPANY 2004-04-22 US claimed
WO-2025132194-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2025-06-26 WO disclosed
US-12246309-B2 Catalytic porous polymer for selective capture and reduction of carbon dioxide UT-BATTELLE, LLC (US) 2025-03-11 US disclosed
CN-117327247-A Polyurea self-contained microporous material with high specific surface area and preparation method thereof 济南大学 2024-01-02 CN disclosed
EP-3630896-B1 ELECTRONIC AND OPTOELECTRONIC DEVICES HAVING ANISOTROPIC PROPERTIES AND METHOD FOR THEIR PRODUCTION INNOVATIONLAB GMBH (DE) 2023-11-29 EP disclosed
US-20230234042-A1 CATALYTIC POROUS POLYMER FOR SELECTIVE CAPTURE AND REDUCTION OF CARBON DIOXIDE UT-BATTELLE, LLC 2023-07-27 US disclosed
CN-110628061-B Polyimide film, optical film, image display device and preparation method of image display device 李南文 2022-05-20 CN disclosed
US-11329229-B2 Hole transporting organic molecules containing enamine groups for optoelectronic and photoelectrochemical devices KAUNO TECHNOLOGIES UNIVERSITETAS (LT) 2022-05-10 US disclosed
WO-1999040655-A1 USE OF SPIRO COMPOUNDS AS LASER DYES AXIVA GMBH (DE) 1999-08-12 WO disclosed
US-5840217-A LIGHT-EMITTING, CHARGE-TRANSPORT, CHARGE-INJECTION MATERIALS HOECHST AKTIENGESELLSCHAFT (DE) 1998-11-24 US disclosed
WO-1998042655-A1 SPIRO COMPOUNDS AND THE USE THEREOF AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO KG (DE) 1998-10-01 WO disclosed
EP-0863931-A2 POLY(9,9'-SPIRO-BISFLUORENES), THE PRODUCTION AND USE OF SAME Ciba SC Holding AG (CH) 1998-09-16 EP disclosed
WO-1998018996-A1 OPTICAL BRIGHTENING AGENT AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO KG (DE) 1998-05-07 WO disclosed
WO-1997020877-A2 POLY(9,9'-SPIRO-BISFLUORENES), THE PRODUCTION AND USE OF SAME CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 1997-06-12 WO disclosed
EP-0676461-A2 Spiro compounds and their application as electroluminescence materials HOECHST AKTIENGESELLSCHAFT (DE) 1995-10-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11329229-B2 Hole transporting organic molecules containing enamine groups for optoelectronic and photoelectrochemical devices OCIAD1, OCIAD2, SLCO4C1 SMN1; SMN2 4478/4885LMNA 3695/4885KDM4E 4217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.